Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
New companies 7 · Follow-on 0
Stages: Series A 3, Undisclosed 3, Growth 1
Anew Labs $290M FundingMath Magic Undisclosed Series A+Full-Life Technologies $150M Series D+DebtNew companies 6 · Follow-on 1
Stages: Undisclosed 3, Series A 2, Series B 1, Series C+ 1
Vivacta Biotechnology $50M Series A+Pulnovo Medical $100M StrategicVivatides Therapeutics $54M Series ANew companies 6 · Follow-on 0
Stages: Series A 3, Undisclosed 2, Growth 1
Anew Labs $290M FundingApex Intelligence Undisclosed AngelInfiMaker Undisclosed Series ANew companies 5 · Follow-on 0
Stages: Seed 2, Undisclosed 2, Series B 1
Anew Labs $290M FundingLatentVerse Undisclosed SeedMoSense Undisclosed AngelNew companies 4 · Follow-on 0
Stages: Seed 1, Series B 1, Series C+ 1, Undisclosed 1
MoSense Undisclosed AngelLitchibot Undisclosed SeedX Square Robot Undisclosed Series CNew companies 4 · Follow-on 0
Stages: Series B 2, Undisclosed 2
Even Realities $150M UndisclosedEvoken ~$300M Series B+SignalPlus $50M Series B1New companies 4 · Follow-on 0
Stages: Series A 3, Seed 1
Vivacta Biotechnology $50M Series A+Vivatides Therapeutics $54M Series AExcalipoint Therapeutics $27.7M Seed+New companies 3 · Follow-on 0
Stages: Series C+ 2, Undisclosed 1
FAIRINO Undisclosed Series DEven Realities $150M UndisclosedX Square Robot Undisclosed Series CNew companies 3 · Follow-on 0
Stages: Seed 2, Series B 1
MetaCircle Undisclosed SeedLitchibot Undisclosed SeedEvoken ~$300M Series B+New companies 3 · Follow-on 0
Stages: Seed 1, Series B 1, Undisclosed 1
Anew Labs $290M FundingSyneron Bio $150M Series BExcalipoint Therapeutics $27.7M Seed+New companies 3 · Follow-on 0
Stages: Undisclosed 2, Series B 1
Anew Labs $290M FundingEvoken ~$300M Series B+Pulnovo Medical $100M StrategicNew companies 3 · Follow-on 0
Stages: Series B 2, Undisclosed 1
DeepCtrls Undisclosed Series B+Evoken ~$300M Series B+StairMed CN¥500M StrategicNew companies 2 · Follow-on 1
Stages: Growth 1, Series B 1, Undisclosed 1
Tripo AI ~$445M Series BROBOTERA $200M GrowthROBOTERA CN¥1B StrategicNew companies 3 · Follow-on 0
Stages: Seed 2, Undisclosed 1
LatentVerse Undisclosed SeedMoSense Undisclosed AngelLitchibot Undisclosed SeedNew companies 3 · Follow-on 0
Stages: Growth 1, Series C+ 1, Undisclosed 1
X Square Robot Undisclosed Series CROBOTERA $200M GrowthStairMed CN¥500M StrategicNew companies 3 · Follow-on 0
Stages: Series C+ 2, Growth 1
ROBOTERA $200M GrowthSiengine >$100M Series CiSpace China CN¥5B Series D++New companies 3 · Follow-on 0
Stages: Undisclosed 2, Series A 1
Vivacta Biotechnology $50M Series A+Pulnovo Medical $100M StrategicStairMed CN¥500M StrategicNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
MHX Technology CN¥1.6B First equity financing agreementInfiMaker Undisclosed Series ANew companies 2 · Follow-on 0
Stages: Series A 2
Moxian Technology Undisclosed Series A+Juxie Intelligent >CN¥100M Series A+New companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Apex Intelligence Undisclosed AngelLitchibot Undisclosed SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
DeepCtrls Undisclosed Series B+Degron Therapeutics $40M Series A+New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Tripo AI ~$445M Series BExcalipoint Therapeutics $27.7M Seed+New companies 2 · Follow-on 0
Stages: Seed 1, Series A 1
Math Magic Undisclosed Series A+LatentVerse Undisclosed SeedNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Math Magic Undisclosed Series A+Moonshot AI $2B Series BNew companies 2 · Follow-on 0
Stages: Series C+ 2
Siengine Undisclosed Series C+iSpace China CN¥5B Series D++New companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Chang Guang Satellite Technology ~CN¥5B Equity financingBYD Semiconductor CN¥800M Series A+ strategic capital increaseNew companies 1 · Follow-on 1
Stages: Series B 1, Undisclosed 1
SignalPlus $50M Series B1SignalPlus $40M StrategicNew companies 2 · Follow-on 0
Stages: Undisclosed 2
Full-Life Technologies $150M Series D+DebtOricell Therapeutics $110M Pre-IPO“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.